Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MODDthis companyModular Medical, Inc.	$1.57	-0.43×	0.93×	0×	-0.21×	36.8%	0.0%	0.0%	0.0%	-217.9%	-206.4%	-229.5%	0.03×	0.25×	0×	4.03×	0.0%	1	-14.77	3	B-
ANTXAN2 Therapeutics, Inc.	$4.04	-0.98×	0.65×	0×	-0.41×	-86.4%	0.0%	0.0%	0.0%	-66.3%	-71.6%	-86.6%	0×	0.57×	0×	6.87×	0.0%	1	12.25	1	C-
BOLDBoundless Bio, Inc.	$2.45	-0.46×	0.27×	0×	-1.02×	-159.7%	0.0%	0.0%	0.0%	-59.0%	-43.0%	-175.9%	0.5×	-0.55×	0×	8.74×	0.0%	1	-3.14	2	C
HYPDHyperion DeFi, Inc.	$2.57	-0.38×	0.43×	21.88×	-0.45×	-153.6%	62.7%	-2333.4%	-5570.6%	-110.4%	-38.3%	-83.0%	0.21×	-0.05×	-12.18×	2.68×	5.0%	6	-0.75	3	B+
IBIOiBio, Inc.	$0.79	-5.47×	2.12×	1,821.05×	-4×	-38.6%	100.0%	-35141.0%	-33044.0%	-38.6%	-40.0%	-13.1%	0.03×	1.7×	-663.04×	7.85×	0.0%	2	-3.05	2	C+
INTSIntensity Therapeutics, Inc.	$2.93	-1.2×	1.17×	0×	-0.18×	143.3%	0.0%	0.0%	0.0%	-97.7%	-99.9%	-66.3%	0.01×	1.02×	0×	5.92×	0.0%	2	-10.06	3	B
Peer median	—	-0.98×	0.65×	0×	-0.45×	-86.4%	0.0%	0.0%	0.0%	-66.3%	-43.0%	-83.0%	0.03×	0.57×	0×	6.87×	0.0%	2	-3.05	2	—